Valuing the benefits and costs of health care programmes: where's the 'extra' in extra-welfarism?
- PMID: 12593883
- DOI: 10.1016/s0277-9536(02)00101-6
Valuing the benefits and costs of health care programmes: where's the 'extra' in extra-welfarism?
Abstract
The application of Sen's notion of capabilities to problems of the allocation of resources to health in the form of an extra-welfarist framework underlies the justification of quality adjusted life years (QALYs) as the method for valuing the benefits of health care. In this paper we critically appraise this application from both conceptual and empirical perspectives. We show that the alleged limitations of the welfarist approach are essentially limitations in its application, not in the capacity of the approach to accommodate the concerns of extra-welfarists. Moreover, the arguments used to justify the application of the extra-welfarist framework are essentially welfarist. We demonstrate that the methods used to measure QALYs share their basic theoretical roots with welfarist valuation methods, such as willingness to pay (WTP). Although QALYs and WTP share many challenges, we argue that WTP provides a method which performs better with respect to those challenges. In the context of evaluating alternative allocations of health care resources we are left asking what is 'extra' in extra-welfarism?
Similar articles
-
Capabilities as menus: a non-welfarist basis for QALY evaluation.J Health Econ. 2013 Jan;32(1):128-37. doi: 10.1016/j.jhealeco.2012.10.004. Epub 2012 Oct 30. J Health Econ. 2013. PMID: 23202258
-
Measuring the social importance of concentration or dispersion of individual health benefits.Health Econ. 2002 Jan;11(1):43-53. doi: 10.1002/hec.643. Health Econ. 2002. PMID: 11788981
-
Welfarism and extra-welfarism: a critical overview.Cad Saude Publica. 2017 Aug 21;33(8):e00014317. doi: 10.1590/0102-311X00014317. Cad Saude Publica. 2017. PMID: 28832769
-
Preferences, needs and QALYs.J Med Ethics. 1996 Oct;22(5):267-72. doi: 10.1136/jme.22.5.267. J Med Ethics. 1996. PMID: 8910777 Free PMC article. Review.
-
Willingness to pay and the valuation of programmes for the prevention and control of influenza.Pharmacoeconomics. 1999;16 Suppl 1:55-61. doi: 10.2165/00019053-199916001-00008. Pharmacoeconomics. 1999. PMID: 10623377 Review.
Cited by
-
The greatest happiness of the greatest number? Policy actors' perspectives on the limits of economic evaluation as a tool for informing health care coverage decisions in Thailand.BMC Health Serv Res. 2008 Sep 26;8:197. doi: 10.1186/1472-6963-8-197. BMC Health Serv Res. 2008. PMID: 18817579 Free PMC article.
-
Are Quality-Adjusted Life Years a Good Proxy Measure of Individual Capabilities?Pharmacoeconomics. 2017 Jun;35(6):637-646. doi: 10.1007/s40273-017-0495-3. Pharmacoeconomics. 2017. PMID: 28238151 Free PMC article.
-
Economic model of community-based falls prevention: seeking methodological solutions in evaluating the efficiency and equity of UK guideline recommendations.BMC Geriatr. 2023 Mar 30;23(1):187. doi: 10.1186/s12877-023-03916-z. BMC Geriatr. 2023. PMID: 36997884 Free PMC article.
-
Is economic evaluation in touch with society's health values?BMJ. 2004 Nov 20;329(7476):1233-6. doi: 10.1136/bmj.329.7476.1233. BMJ. 2004. PMID: 15550430 Free PMC article. Review.
-
The impact of economic evaluation on quality management in spine surgery.Eur Spine J. 2009 Aug;18 Suppl 3(Suppl 3):338-47. doi: 10.1007/s00586-009-0939-3. Epub 2009 Apr 1. Eur Spine J. 2009. PMID: 19337760 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources